Assess Safety and Immunogenicity of A/H5 Inactivated Monovalent Influenza Vaccines at Different Antigen Dose Levels Adjuvanted With AS03 or MF59
Clinical trial NCT06560151 · COMPLETED
Trial details
- NCT number
- NCT06560151
- Sponsor
- Biomedical Advanced Research and Development Authority
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-21
- Primary completion
- 2025-01-16
- Enrollment
- 1380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.